文献速递外周动脉疾病

股腘动脉慢性完全闭塞顺行导丝-导管通过失败的危险因素分析

Risk Factor Analysis for Crossing Failure in Primary Antegrade Wire-Catheter Approach for Femoropopliteal Chronic Total Occlusions.
PubMed 文献 · J Endovasc Ther · 2022-04-10

单中心回顾性分析2018年5月至2020年2月300例股腘动脉慢性完全闭塞患者,评估顺行导丝-导管通过失败的危险因素。初次通过成功率为70%(n=210),辅助通过成功率增至89%(n=267)。钙化、环形钙化、CTOP III或IV型、股浅动脉近端闭塞及P3段闭塞与顺行通过失败风险增加相关。

要点

  • 初次顺行通过成功率为70%,使用再入装置或顺行-逆行联合途径后辅助通过成功率增至89%。
  • 钙化(OR=4.2)、环形钙化(OR=2.5)、CTOP III或IV型(OR=1.9)、股浅动脉近端闭塞(OR=3.5)及P3段闭塞(OR=4.1)与顺行通过失败风险增加相关。
  • 慢性完全闭塞形态、钙化负荷及病变位置是顺行通过失败的独立危险因素。

核心结论

  • 慢性完全闭塞形态、钙化负荷及病变位置被确定为顺行通过失败的独立危险因素。
  • 使用替代通过策略可显著提高总体通过成功率。

研究设计与样本

  • 单中心回顾性分析,纳入2018年5月至2020年2月期间接受治疗的股腘动脉慢性完全闭塞患者300例。
  • 主要终点为初次通过成功,定义为未使用逆行入路、通过或再入装置的成功顺行通过;同时分析辅助通过成功。
  • 采用逻辑回归分析确定顺行通过失败的危险因素。

主要发现

  • 183例(61%)表现为生活方式受限性跛行。
  • 平均病变长度为180 mm(四分位距100-260 mm),慢性完全闭塞中位长度为100 mm(四分位距50-210 mm)。
  • 基于斑块形态的慢性完全闭塞通过(CTOP)分型:I型9%(n=26),II型61%(n=183),III型8%(n=25),IV型22%(n=66)。
  • 基于外周动脉钙化评分量表(PACSS)、外周学术研究联盟(PARC)及360°分级系统的严重钙化分别见于17%、24%和28%的病变。
  • 对侧股动脉入路用于278例(93%);初次通过成功率为70%(n=210),使用再入装置28例(9%)或顺行-逆行联合途径11%(n=34)使辅助通过成功率增至89%(n=267)。

关键数值与推荐

  • 钙化与顺行通过失败风险增加相关(OR=4.2,95%CI=1.7-10.2)。
  • 环形钙化与顺行通过失败风险增加相关(OR=2.5,95%CI=1.3-4.9)。
  • CTOP III或IV型与顺行通过失败风险增加相关(OR=1.9,95%CI=1.4-2.6)。
  • 股浅动脉近端闭塞与顺行通过失败风险增加相关(OR=3.5,95%CI=1.7-7.4)。
  • P3段慢性完全闭塞与顺行通过失败风险增加相关(OR=4.1,95%CI=1.5-10.8)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Antegrade wire-catheter crossing remains the primary approach for femoropopliteal interventions. Nonetheless, data reporting on crossing failure are limited. Aim of this study is to identify risk factors for antegrade crossing failure in patients with femoropopliteal chronic total occlusions (CTOs). METHODS: This is a single-center, retrospective analysis. Patients with femoropopliteal CTOs treated between May 2018 and February 2020 were included into this study. Primary endpoint of this analysis was primary crossing success defined as successful antegrade crossing without the use of retrograde access, crossing or re-entry devices. The assisted crossing success was additionally analyzed. A logistic regression analysis identified risk factors for failed primary antegrade crossing. RESULTS: Data from 300 patients were analyzed. The majority (n=183, 61%) presented with lifestyle limiting claudication. The mean lesion length was 180 mm [interquartile range (IQR) 100-260 mm], whereas the median CTO length was 100 mm (IQR=50-210 mm). A chronic total occlusion crossing approach based on plaque morphology (CTOP) type I configuration was observed in 9% (n=26) of the lesions, type II in 61% (n=183), type III in 8% (n=25), and type IV in 66 CTOs (n= 66, 22%). Severe calcification based on the Peripheral Arterial Calcium Scoring Scale (PACSS), Peripheral Academic Research Consortium (PARC), and 360° grading systems was identified in 17%, 24%, and 28% of the lesions, respectively. A contralateral femoral access was used in 278 cases (93%). The primary crossing success amounted to 70% (n=210). The use of a re-entry device in 28 patients (9%) or of a combined antegrade-retrograde approach in 11% (n=34) of the cases increased the assisted crossing success to 89% (n=267). The presence of calcification (odds ratio [OR]=4.2, 95% CI=1.7-10.2) or of circumferential calcium (OR=2.5, 95% CI=1.3-4.9), a CTOP class ΙΙΙ or ΙV (OR=1.9, 95% CI=1.4-2.6), a proximal superficial femoral artery (SFA) occlusion (OR=3.5, 95% CI=1.7-7.4) and a CTO at P3 (OR=4.1, 95% CI=1.5-10.8) were associated with an increased risk for antegrade crossing failure. CONCLUSIONS: In this study, chronic total occlusions (CTO) morphology, calcification burden, and lesion's location were identified as independent risk factors for failed antegrade crossing. Nonetheless, the use of alternative crossing strategies significantly increased the overall crossing success.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Bernardini G, Bisdas T, Argyriou A, et al. Risk Factor Analysis for Crossing Failure in Primary Antegrade Wire-Catheter Approach for Femoropopliteal Chronic Total Occlusions. J Endovasc Ther. 2022. PMID: 35403499. doi:10.1177/15266028221083456

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。